High Rates of Health Care Utilization in Pediatric Multiple Sclerosis: A Canadian Population-based Study
Overview
Authors
Affiliations
We aimed to compare health care utilization of children with pediatric-onset multiple sclerosis to that of age, sex and geographically-matched children without multiple sclerosis. Using population-based administrative data from Ontario, Canada for the period 2003-2014, we applied a validated case definition to identify persons aged ≤18 years with multiple sclerosis. We identified up to 5 children without multiple sclerosis matched on sex, age, and region of residence. In each cohort, we determined annual rates of any hospitalization and physician services use. Using general linear models we compared utilization rates adjusting for age, sex, region, socioeconomic status and year. Subsequently, we limited the analysis to incident cases of multiple sclerosis and their matches, and compared rates of utilization in the year of multiple sclerosis diagnosis, and the three years thereafter. We identified 659 youth with multiple sclerosis (428 incident cases), and 3,294 matched controls. Two-thirds of both cohorts were female. After adjustment for sociodemographic factors and year, the multiple sclerosis cohort was more likely to be hospitalized than the matched cohort (odds ratio 15.2; 95%CI: 12.0, 19.1), and had higher rates of ambulatory physician visits (rate ratio 4.58; 95%CI: 4.26, 4.92). The odds of hospitalization (odds ratio 40.1; 95%CI: 27.1, 59.5) and physician visits (rate ratio 5.14; 95%CI: 4.63, 5.71) were markedly elevated in the year of MS diagnosis, declining thereafter but remaining elevated versus the matched cohort. Children with multiple sclerosis have substantially elevated rates of health care utilization as compared to matched children without multiple sclerosis, over calendar time and throughout the early disease course.
Symptoms Prior to Diagnosis of Multiple Sclerosis in Individuals Younger Than 18 Years.
Akmatov M, Graf J, Kohring C, Ellenberger D, Batzing J, Tremlett H JAMA Netw Open. 2024; 7(12):e2452652.
PMID: 39729316 PMC: 11681376. DOI: 10.1001/jamanetworkopen.2024.52652.
The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis.
Greene N, Araujo L, Campos C, Dalglish H, Gibbs S, Yermilov I J Health Econ Outcomes Res. 2022; 9(2):103-114.
PMID: 36348724 PMC: 9584745. DOI: 10.36469/001c.37992.
From the prodromal stage of multiple sclerosis to disease prevention.
Marrie R, Allegretta M, Barcellos L, Bebo B, Calabresi P, Correale J Nat Rev Neurol. 2022; 18(9):559-572.
PMID: 35840705 DOI: 10.1038/s41582-022-00686-x.
The Multiple Sclerosis Prodrome: Evidence to Action.
Tremlett H, Munger K, Makhani N Front Neurol. 2022; 12:761408.
PMID: 35173664 PMC: 8841819. DOI: 10.3389/fneur.2021.761408.
Emadi M, Delavari S, Bayati M BMC Public Health. 2021; 21(1):1771.
PMID: 34583668 PMC: 8480106. DOI: 10.1186/s12889-021-11793-7.